Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002958575 | SCV003277179 | likely benign | not provided | 2024-01-21 | criteria provided, single submitter | clinical testing | |
Ce |
RCV002958575 | SCV004153206 | benign | not provided | 2023-11-01 | criteria provided, single submitter | clinical testing | TCF20: BP3, BS1, BS2 |
Gene |
RCV002958575 | SCV005326063 | uncertain significance | not provided | 2023-10-16 | criteria provided, single submitter | clinical testing | In-frame deletion of 1 amino acid in a non-repeat region; In silico analysis supports that this variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Prevention |
RCV003943635 | SCV004764299 | likely benign | TCF20-related disorder | 2022-02-03 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |